Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis

Nephrology

Volumn 14, Issue 3, 2009, Pages 327-331

  Hayakawa, Kazuyoshi ^b   Ohashi, Hiroshige ^c   Yokoyama, Haruko ^c   Yoshida, Gakuro ^c   Okada, Miho ^c   Minatoguchi, Shinya ^a,d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gihoku General Hospital   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d GIFU UNIVERSITY   (Japan)

Author keywords

Adiponectin; Chronic glomerulonephritis; Leptin; Proteinuria

Indexed keywords

ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEPTIN; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA;

ADIPONECTIN; ADULT; AGED; CHRONIC DISEASE; FEMALE; GLOMERULONEPHRITIS; HUMANS; LEPTIN; MALE; MIDDLE AGED; PROTEINURIA;

EID: 65349146463     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01047.x     Document Type: Article

References (26)

1. Halvorsen YD, Wilkinson WO, Briggs MR. Human adipocyte proteomics - A complementary way of looking at fat. Pharmacogenomics 2000 1 : 179 85.
2. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 : 425 32.
3. Halle M, Berg A, Northoff H, Keul J. Importance of TNF-alpha and leptin in obesity and insulin resistance: A hypothesis on the impact of physical exercise. Exerc. Immunol. Rev. 1998 4 : 77 94.
4. Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel specific collagen-like receptor, apM1. Biochem. Biophys. Res. Commun. 1996 221 : 286 9.
5. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999 100 : 2473 6.
6. Mantzoros CS, Li T, Manson JE et al. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J. Clin. Endcrinol. Metab. 2005 90 : 4542 8.
7. Wallace AM, McMahon AD, Packard CJ et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2004 104 : 3052 6.
8. Zoccali C, Mallamaci F, Cuzzola F et al. Metabolic and hemodynamic correlates of adiponectin, the most abundant adipocyte-derived protein, in human hypertension. J. Am. Soc. Nephrol. 2002 11 : A1865.
9. Merabet E, Dagogo-Jack S, Coyne DW et al. Increased plasma leptin concentration in end-stage renal disease. J. Am. Soc. Nephrol. 1997 82 : 847 50.
10. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2002 13 : 134 41.
11. Imai E, Horio M, Nitta K et al. Modification of the modification of diet in renal disease study equation for Japan. Am. J. Kidney Dis. 2007 50 : 927 37.
12. Okamoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 2000 32 : 47 50.
13. Nakamura Y, Shimada K, Fukuda D et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004 90 : 528 33.
14. Kadowaki T, Yamauchi T, Kubota N et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006 116 : 1784 92.
15. Cote M, Mauriege P, Bergeron J et al. Adiponectinemia in visceral obesity: Impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 2005 90 : 1434 9.
16. Esposito K, Pontillo A, DiPalo C et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese woman: A randomized trial. JAMA 2003 9 : 1799 804.
17. Maeda N, Takahashi M, Funahashi T et al. PPARgamma ligands increase expression and plasma concentration of adiponectin, an adipose-derived protein. Diabetes 2001 50 : 2094 9.
18. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 : 425 32.
19. Zoccal C, Mallamaci F, Tripepi G et al. Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease. Kidney Int. 2003 S84 : S65 8.
20. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997 46 : 2040 43.
21. Watts GF, Herrmann S, Dogra GK et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int. 2001 60 : 182 9.
22. Dorga GK, Watts GF, Herrmann S et al. Statin therapy improves brachial artery endothelial function in nephrotic syndrome. Kidney Int. 2002 62 : 550 57.
23. Scherer PE, Williams S, Fogliano M et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995 270 : 26746 9.
24. Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int. J. Obesity. 1997 20 : 1120 26.
25. Schroth M, Groshl M, Dorr HG et al. Renal loss of leptin in patients with nephritic syndrome. Europ. J. Endocri. 2001 145 : 463 8.
26. Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis. Kidney Int. 1999 56 : 860 72.